Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes
Clinical trial NCT01342484 · COMPLETED
Trial details
- NCT number
- NCT01342484
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2016-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.